Identification of acquired antimicrobial resistance genes | 2012/07/10 | English | 3,588 |
Determination of minimum inhibitory concentrations | 2001/07/01 | English | 2,523 |
Synergy, antagonism, and what the chequerboard puts between them | 2003/06/12 | English | 1,738 |
ResFinder 4.0 for predictions of phenotypes from genotypes | 2020/08/11 | English | 1,388 |
Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae | 2010/01/12 | English | 1,195 |
Photodynamic antimicrobial chemotherapy (PACT) | 1998/07/01 | | 898 |
OXA-48-like carbapenemases: the phantom menace | 2012/04/11 | English | 649 |
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15 | 2007/12/19 | English | 626 |
CTX-M: changing the face of ESBLs in Europe | 2006/11/13 | English | 626 |
Efflux-mediated antimicrobial resistance | 2005/05/24 | English | 618 |
Resistance in the environment | 2004/07/01 | English | 588 |
Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data | 2003/12/04 | English | 586 |
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review | 2007/10/03 | English | 575 |
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain | 2010/11/16 | English | 562 |
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines | 2006/05/30 | English | 555 |
Biosurfactants: potential applications in medicine | 2006/02/09 | English | 526 |
Mycobacterium abscessus: a new antibiotic nightmare | 2012/01/30 | English | 525 |
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community | 2005/05/25 | English | 511 |
Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae | 2018/01/23 | English | 506 |
The European ban on growth-promoting antibiotics and emerging consequences for human and animal health | 2003/07/01 | English | 504 |
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis | 2012/07/24 | English | 500 |
Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants | 2010/10/08 | English | 498 |
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype | 2017/05/25 | English | 497 |
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? | 2004/12/01 | English | 492 |
Significance of antibiotics in the environment | 2003/06/12 | English | 489 |
The changing epidemiology of resistance | 2009/08/12 | English | 473 |
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions | 2000/08/01 | | 470 |
Global spread of carbapenem-resistant Acinetobacter baumannii | 2009/12/08 | English | 464 |
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology | 2013/12/29 | English | 461 |
Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases | 2005/11/10 | English | 461 |